EUCTR2005-003132-21-AT进行中（未招募）1 期
European Intravitreal Avastin® Trial 1 - EURIVAT1
Dept. of Ophthalmology, Medical University of Vienna0 个研究点目标入组 60 人开始时间: 2005年8月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Signed informed consent.
- •Age >50 years.
- •Primary subfoveal choroidal neovascularization lesions secondary to AMD in the study eye.
- •Best corrected visual acuity, using ETDRS charts, of 20/800 to 20/40 (Snellen equivalent) in the study eye.
- •Lesion size smaller than 4 disc areas as assessed by flourescein angiography.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Prior/concomitant treatment.
- •Previous subfoveal focal laser photocoagulation in the study eye.
- •Laser photocoagulation (juxtafoveal or extrafoveal) in the study eye within 1 month preceding Day 0.
- •History of submacular surgery or other surgical intervention for AMD in the study eye.
- •Previous participation in any studies of investigational drugs within 1 month preceding Day 0 (excluding vitamins and minerals).
- •Lesion characteristics:
- •Subfoveal fibrosis or atrophy in the study eye.
- •Concurrent ocular conditions:
- •Any concurrent intraocular condition in the study eye (e.g., cataract or diabetic retinopathy) that, in the opinion of the investigator, could either require medical or surgical intervention during the 24-month study period to prevent or treat visual loss that might result from that condition, or if allowed to progress untreated, could likely contribute to loss of at least 2 Snellen equivalent lines of best corrected visual acuity over the 24-month study period.
- •Active intraocular inflammation (grade trace or above) in the study eye.
- •Current vitreous hemorrhage in the study eye.
- •History of idiopathic or autoimmune-associated uveitis in either eye.
- •Infectious conjunctivitis, keratitis, scleritis, or endophthalmitis in either eye.
- •Intraocular surgery (including cataract surgery) in the study eye within 2 months preceding Day 0.
- •Uncontrolled ocular hypertension in the study eye (defined as intraocular pressure >30 mmHg).
- •Concurrent systemic conditions:
- •History of any disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding giving reasonable suspicion of a disease or condition that contraindicates the use of an investigational drug or that might affect interpretation of the results of the study or render the subject at high risk for treatment complications.
- •Current treatment fo active systemic infection.
- •History of allergy to fluorescein, not amenable to treatment.
- •Inability to obtain fundus photographs or flourescein angiograms of sufficient quality to be analyzed and graded by the central reading center.
- •Inability to comply with study or follow up procedures.
研究者
相似试验
招募中
不适用
Clinical study of the Avastin intravitreal injection to thick macula after surgery of epiretinal membraneEpiretinal MembraneJPRN-UMIN000015286Okayama University Hospital30
已完成
不适用
Treatment With Intravitreal Avastin for Large Uveal MelanomasUveal MelanomaNCT00596362Memorial Sloan Kettering Cancer Center1
已完成
不适用
The effects of ?Avastin in patients with age-related macular degeneratioage-related macular degeneration.Visual disturbances and blindnessH53,H54IRCT2014070218323N1Birjand University of Medical Sciences76
进行中（未招募）
不适用
Intravitreal Bevacizumab Avastin, Roche, United Kingdom for exudative maculopathies - Intravitreal bevacizumabEUCTR2005-006182-14-ITIVERSITA DEGLI STUDI DI UDINE30
招募中
1 期
Intravitreous Avastin for diseases of ocular angiogensisAge Related Macular DegenerationProliferative Diabetic retinopathyEye - Diseases / disorders of the eyeMetabolic and Endocrine - DiabetesNeovascular GlaucomaACTRN12607000244404Royal Victorian Eye and Ear Hospital50